## SNPS: Synopsys, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 1.0% below STRENGTH zone (3.0-6.0%); PEG 2.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($448.90)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. Key facts: Synopsys Q3 revenue falls; class action lawsuit filed**
- Source: TradingView — Track All Markets | 20251227T200804 | Bearish | Relevance: 100%
- Synopsys (SNPS) reported Q3 revenue of $1.740 billion, falling short of guidance and resulting in a 43% year-over-year decrease in net income. Following this announcement, the company's stock price dropped by 35.84%, and a class action lawsuit has been filed against Synopsys on behalf of investors alleging securities fraud between December 4, 2024, and September 9, 2025.

**2. SNPS Shareholders Have Opportunity to Lead Synopsys, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!**
- Source: FOX40 News | 20251227T110824 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Synopsys, Inc. (NASDAQ:SNPS) on behalf of investors who purchased securities between December 4, 2024, and September 9, 2025. The lawsuit alleges that Synopsys made materially false and misleading statements regarding its business, operations, and prospects, specifically concerning the deteriorating economics of its Design IP business due to increased focus on AI customers. Investors who suffered losses have until December 30, 2025, to request to be appointed lead plaintiff.

**3. Lost Money on Synopsys, Inc. (SNPS)? Join Class Action Before December 30, 2025 - Contact Levi & Korsinsky**
- Source: CBS 42 | 20251227T040824 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has announced a securities class action lawsuit against Synopsys, Inc. (NASDAQ:SNPS) on behalf of investors who suffered losses due to alleged securities fraud between December 4, 2024, and September 9, 2025. The lawsuit claims Synopsys concealed that its increased focus on AI customers was negatively impacting its Design IP business economics and that its positive statements were misleading. Investors are encouraged to contact Levi & Korsinsky to understand their rights before the December 30, 2025, deadline.

**4. Synopsys 96 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuits Against Synopsys, Inc. - SNPS**
- Source: The AI Journal | 20251226T200852 | Bearish | Relevance: 100%
- Kahn Swick & Foti, LLC (KSF) and former Louisiana Attorney General Charles C. Foti, Jr., are reminding Synopsys, Inc. (SNPS) investors that they have until December 30, 2025, to apply for lead plaintiff in a securities class action lawsuit. This alert is for investors who purchased Synopsys securities between December 4, 2024, and September 9, 2025, or acquired Synopsys common stock for their Ansys, Inc. shares. The lawsuits allege that Synopsys failed to disclose material information, leading to a significant stock price drop after disappointing Q3 2025 financial results and guidance.

**5. Synopsys 96 Hour Deadline Alert: Former Louisiana Attorney General And Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuits Against Synopsys, Inc. - SNPS**
- Source: Business Wire | 20251226T200830 | Bearish | Relevance: 100%
- Kahn Swick & Foti, LLC (KSF) and former Louisiana Attorney General Charles C. Foti, Jr., are reminding investors of a December 30, 2025 deadline to file lead plaintiff applications in securities class action lawsuits against Synopsys, Inc. The lawsuits allege that Synopsys failed to disclose material information during the Class Period, leading to significant financial losses for investors. The claims stem from Synopsys's 3Q2025 financial results, which missed guidance and showed a decline in revenue and net income, causing a substantial drop in share price.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 6, Lowers: 4)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Morgan Stanley | $550 | $510 | +8% |
| 2025-12-11 | JP Morgan | $650 | $600 | +8% |
| 2025-12-11 | Wells Fargo | $500 | $445 | +12% |
| 2025-12-11 | Keybanc | $600 | $575 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Morgan Stanley | main | Overweight |
| 2025-12-11 | JP Morgan | main | Overweight |
| 2025-12-11 | Wells Fargo | main | Equal-Weight |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.00M) |
| Sells | 4 ($0.06M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+20.7%)
- Blackrock Inc.: 7.9% (+18.5%)
- State Street Corpora: 4.6% (+20.6%)
- Capital World Invest: 3.9% (-3.7%)
- FMR, LLC: 3.0% (+47.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 6 raises (avg +8%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 2.99 signals overvaluation risk, limited margin of safety. Quality metrics strong (margin 19%). Analyst sentiment positive (6 raises, avg +8%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $91.3B |
| Beta | 1.15 |
| 52W Range | $365.74 - $651.73 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.99 |
| Forward P/E | 28.2 |
| Current P/E | 33.2 |
| YoY Growth | 17.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 0.0% to 1.0% (+1.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.0pp (needs >3.0% for momentum thesis). MRS_5 at 0.1% confirms short-term momentum alignment. Below SMA200 (0.97x), long-term trend not supportive. MACD histogram positive (1.34), confirming momentum. OFD pattern: +SLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.04% (CS: 88) | Neutral |
| RSI_14 | 62.3 | Neutral |
| MACD Histogram | 1.34 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.090x | Above |
| vs SMA200 | 0.975x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $477.14
- **Stop Loss:** $448.90 (5.9% risk)
- **Target:** $505.38 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 38
- **Position Value:** $18,131.32
- **Portfolio %:** 18.13%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with selective risk appetite amid holiday trading. VIX at extreme lows (13.6) signals complacency while positive yield curve (+59bps) and stable economic data support continuation. Focus on quality names with AI/infrastructure exposure while monitoring January volatility reset.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.88 | $2.90 | +0.7% |
| 2025Q3 | $3.75 | $3.39 | -9.5% |
| 2025Q2 | $3.40 | $3.67 | +8.0% |
| 2025Q1 | $2.79 | $3.03 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*